| NaLi-H1: A universal synthetic library of humanized nanobodies providing highly functional antibodies and intrabodies S Moutel, N Bery, V Bernard, L Keller, E Lemesre, A De Marco, L Ligat, ... Elife 5, e16228, 2016 | 287 | 2016 |
| Small molecule inhibitors of RAS-effector protein interactions derived using an intracellular antibody fragment CE Quevedo, A Cruz-Migoni, N Bery, A Miller, T Tanaka, D Petch, ... Nature communications 9 (1), 3169, 2018 | 124 | 2018 |
| Structure-based development of new RAS-effector inhibitors from a combination of active and inactive RAS-binding compounds A Cruz-Migoni, P Canning, CE Quevedo, CJR Bataille, N Bery, A Miller, ... Proceedings of the National Academy of Sciences 116 (7), 2545-2550, 2019 | 120 | 2019 |
| Structural and functional characterization of a DARPin which inhibits Ras nucleotide exchange S Guillard, P Kolasinska-Zwierz, J Debreczeni, J Breed, J Zhang, N Bery, ... Nature communications 8 (1), 16111, 2017 | 90 | 2017 |
| KRAS-specific inhibition using a DARPin binding to a site in the allosteric lobe N Bery, S Legg, J Debreczeni, J Breed, K Embrey, C Stubbs, ... Nature Communications 10 (1), 2607, 2019 | 87 | 2019 |
| A potent KRAS macromolecule degrader specifically targeting tumours with mutant KRAS N Bery, A Miller, T Rabbitts Nature Communications 11 (1), 3233, 2020 | 85 | 2020 |
| BRET-based RAS biosensors that show a novel small molecule is an inhibitor of RAS-effector protein-protein interactions N Bery, A Cruz-Migoni, CJR Bataille, CE Quevedo, H Tulmin, A Miller, ... Elife 7, e37122, 2018 | 58 | 2018 |
| RNase H2, mutated in Aicardi‐Goutières syndrome, resolves co-transcriptional R-loops to prevent DNA breaks and inflammation A Cristini, M Tellier, F Constantinescu, C Accalai, LO Albulescu, ... Nature communications 13 (1), 2961, 2022 | 49 | 2022 |
| Chromatibody, a novel non-invasive molecular tool to explore and manipulate chromatin in living cells D Jullien, J Vignard, Y Fedor, N Béry, A Olichon, M Crozatier, M Erard, ... Journal of cell science 129 (13), 2673-2683, 2016 | 48 | 2016 |
| A targeted protein degradation cell-based screening for nanobodies selective toward the cellular RHOB GTP-bound conformation N Bery, L Keller, M Soulie, R Gence, AL Iscache, J Cherier, S Cabantous, ... Cell chemical biology 26 (11), 1544-1558. e6, 2019 | 35 | 2019 |
| Single domain antibodies with VH hallmarks are positively selected during panning of llama (Lama glama) naïve libraries A Monegal, A Olichon, N Bery, T Filleron, G Favre, A de Marco Developmental & Comparative Immunology 36 (1), 150-156, 2012 | 34 | 2012 |
| Selection and characterization of a nanobody biosensor of GTP-bound RHO activities L Keller, N Bery, C Tardy, L Ligat, G Favre, TH Rabbitts, A Olichon Antibodies 8 (1), 8, 2019 | 28 | 2019 |
| Bioluminescence Resonance Energy Transfer 2 (BRET2)‐based RAS biosensors to characterize RAS inhibitors N Bery, TH Rabbitts Current Protocols in Cell Biology 83 (1), e83, 2019 | 12 | 2019 |
| Surfaceome interrogation using an RNA-seq approach highlights leukemia initiating cell biomarkers in an LMO2 T cell transgenic model H Pais, K Ruggero, J Zhang, O Al-Assar, N Bery, R Bhuller, V Weston, ... Scientific Reports 9 (1), 5760, 2019 | 11 | 2019 |
| Antibody-based approaches to target pancreatic tumours M Sorbara, P Cordelier, N Bery Antibodies 11 (3), 47, 2022 | 10 | 2022 |
| A cell-based screening method using an intracellular antibody for discovering small molecules targeting the translocation protein LMO2 N Bery, CJR Bataille, A Russell, A Hayes, F Raynaud, S Milhas, S Anand, ... Science Advances 7 (15), eabg1950, 2021 | 9 | 2021 |
| Nanobody-based quantification of GTP-bound RHO conformation reveals RHOA and RHOC activation independent from their total expression in breast cancer L Keller, C Tardy, L Ligat, J Gilhodes, T Filleron, N Bery, P Rochaix, ... Analytical Chemistry 93 (15), 6104-6111, 2021 | 5 | 2021 |
| Competitive SPR using an intracellular anti-LMO2 antibody identifies novel LMO2-interacting compounds P Canning, C Bataille, N Bery, S Milhas, A Hayes, F Raynaud, A Miller, ... Journal of Immunological Methods 494, 113051, 2021 | 4 | 2021 |
| Cytidine deaminase protects pancreatic cancer cells from replicative stress and drives resistance to DNA-targeting drugs A Lumeau, N Bery, A Francès, M Gayral, C Ribeyre, C Lopez, A Névot, ... bioRxiv, 2021.10. 23.465566, 2021 | 3 | 2021 |
| Defeating gemcitabine resistance in pancreatic tumours with antibody-based CDA degrader M Sorbara, C Lopez, A Faihy, L Ligat, P Cordelier, N Bery Pancreatology 23, e12, 2023 | 1 | 2023 |
